Ace Cardiopathy Solutions
Ace Cardiopathy Solutions Pvt Ltd is a young, professionally managed company dedicated to growing nationally and internationally in the medical device industry. They have associations with renowned industry leaders and a passionate, experienced team specializing in neurology, cardiology, and peripheral interventions. The company emphasizes ethical practices, innovation, and customer satisfaction, with a focus on high-quality, in-house produced medical devices and solutions for various cardiovascular and neurovascular procedures.
Industries
Nr. of Employees
small (1-50)
Ace Cardiopathy Solutions
Fifth Floor, Krishna Apra Business Square, Netaji Subhash Place, Pitampura, Delhi-110034
Products
Sirolimus-eluting coronary stent (65 µm strut)
Coronary drug-eluting stent platform with 65 µm strut thickness, open/closed cell architecture and biodegradable PLA polymer coating designed for controlled sirolimus release.
Everolimus-eluting coronary stent (60 µm strut)
Coronary drug-eluting stent using a cobalt‑chromium platform with 60 µm struts, PLGA biodegradable polymer coating and timed everolimus release.
Semi-compliant balloon catheter
Balloon catheter engineered for low crossing profile, enhanced trackability, integrated radiopaque markers and advanced hydrophilic coating for lesion crossing.
Non-compliant balloon catheter
Non-compliant balloon catheter optimized for focused inflation force, controlled stent post-dilation and high trackability with lubricious coatings.
Diagnostic catheter (4F–6F)
Sterile diagnostic catheter line for coronary angiography available in 4F–6F sizes with materials selected for optimal torque response and shape retention.
Guiding catheter
Sterile guiding catheter for interventional procedures designed to provide lumen access and support for therapeutic device delivery.
Sirolimus-eluting coronary stent (65 µm strut)
Coronary drug-eluting stent platform with 65 µm strut thickness, open/closed cell architecture and biodegradable PLA polymer coating designed for controlled sirolimus release.
Everolimus-eluting coronary stent (60 µm strut)
Coronary drug-eluting stent using a cobalt‑chromium platform with 60 µm struts, PLGA biodegradable polymer coating and timed everolimus release.
Semi-compliant balloon catheter
Balloon catheter engineered for low crossing profile, enhanced trackability, integrated radiopaque markers and advanced hydrophilic coating for lesion crossing.
Non-compliant balloon catheter
Non-compliant balloon catheter optimized for focused inflation force, controlled stent post-dilation and high trackability with lubricious coatings.
Diagnostic catheter (4F–6F)
Sterile diagnostic catheter line for coronary angiography available in 4F–6F sizes with materials selected for optimal torque response and shape retention.
Guiding catheter
Sterile guiding catheter for interventional procedures designed to provide lumen access and support for therapeutic device delivery.
Services
Regional commercialization and supply of interventional cardiovascular devices and consumables.
On-site medical and technical assistance for device use in cath labs and operating rooms, including 24x7 emergency support.
Modular training programs and educational initiatives focusing on transradial intervention, perfusion strategies and procedural best practices.
Provision of contrast media and related packaging/handling options to support imaging across modalities.
Regional commercialization and supply of interventional cardiovascular devices and consumables.
On-site medical and technical assistance for device use in cath labs and operating rooms, including 24x7 emergency support.
Modular training programs and educational initiatives focusing on transradial intervention, perfusion strategies and procedural best practices.
Provision of contrast media and related packaging/handling options to support imaging across modalities.
Expertise Areas
- Interventional cardiology
- Interventional neurology (neurovascular interventions)
- Cardiac surgery and perfusion systems
- Peripheral vascular intervention
Key Technologies
- Drug-eluting stents (sirolimus, everolimus)
- Biodegradable polymer coatings (PLA, PLGA) with controlled release
- Cobalt‑chromium and nitinol stent platforms
- Hydrophilic surface coatings
News & Updates
Achieved more than 50 million dollar revenue in 2023
The company achieved a revenue turnover of over 50 million dollars in 2023 and continues to grow.
Awarded as the best place to work for 5 consecutive years
The company has been recognized as the best place to work for the past five years.
Fastest-growing company award
The company was awarded as the fastest-growing company ever.
Revenue Milestone 2023
Achieved over 50 million dollar revenue in 2023.
Best Place to Work Award
Recognized as the best place to work for five consecutive years.
Fastest Growing Company
Awarded as the fastest-growing company.
Achieved more than 50 million dollar revenue in 2023
The company achieved a revenue turnover of over 50 million dollars in 2023 and continues to grow.
Awarded as the best place to work for 5 consecutive years
The company has been recognized as the best place to work for the past five years.
Fastest-growing company award
The company was awarded as the fastest-growing company ever.
Revenue Milestone 2023
Achieved over 50 million dollar revenue in 2023.
Best Place to Work Award
Recognized as the best place to work for five consecutive years.
Fastest Growing Company
Awarded as the fastest-growing company.